JP2016512555A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512555A5 JP2016512555A5 JP2016501805A JP2016501805A JP2016512555A5 JP 2016512555 A5 JP2016512555 A5 JP 2016512555A5 JP 2016501805 A JP2016501805 A JP 2016501805A JP 2016501805 A JP2016501805 A JP 2016501805A JP 2016512555 A5 JP2016512555 A5 JP 2016512555A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- aki
- stem cells
- placental stem
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 10
- 208000033626 Renal failure acute Diseases 0.000 claims 10
- 201000011040 acute kidney failure Diseases 0.000 claims 10
- 210000004991 placental stem cell Anatomy 0.000 claims 7
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims 6
- 208000024891 symptom Diseases 0.000 claims 5
- 230000003247 decreasing effect Effects 0.000 claims 4
- 229940109239 creatinine Drugs 0.000 claims 3
- 206010006326 Breath odour Diseases 0.000 claims 1
- 208000006017 Cardiac Tamponade Diseases 0.000 claims 1
- 206010010904 Convulsion Diseases 0.000 claims 1
- 208000000059 Dyspnea Diseases 0.000 claims 1
- 206010013975 Dyspnoeas Diseases 0.000 claims 1
- 208000002513 Flank pain Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 1
- 101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 102000003729 Neprilysin Human genes 0.000 claims 1
- 108090000028 Neprilysin Proteins 0.000 claims 1
- 206010030124 Oedema peripheral Diseases 0.000 claims 1
- 206010037423 Pulmonary oedema Diseases 0.000 claims 1
- 206010072226 Renal vascular thrombosis Diseases 0.000 claims 1
- 208000025371 Taste disease Diseases 0.000 claims 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims 1
- 206010044565 Tremor Diseases 0.000 claims 1
- 206010047700 Vomiting Diseases 0.000 claims 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 claims 1
- 230000004596 appetite loss Effects 0.000 claims 1
- 206010003119 arrhythmia Diseases 0.000 claims 1
- 230000006793 arrhythmia Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 208000027503 bloody stool Diseases 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 206010013781 dry mouth Diseases 0.000 claims 1
- 208000001780 epistaxis Diseases 0.000 claims 1
- 230000029142 excretion Effects 0.000 claims 1
- 206010016256 fatigue Diseases 0.000 claims 1
- 230000024924 glomerular filtration Effects 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 208000035861 hematochezia Diseases 0.000 claims 1
- 208000014617 hemorrhoid Diseases 0.000 claims 1
- 208000019017 loss of appetite Diseases 0.000 claims 1
- 235000021266 loss of appetite Nutrition 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 235000019656 metallic taste Nutrition 0.000 claims 1
- 230000027939 micturition Effects 0.000 claims 1
- 201000008383 nephritis Diseases 0.000 claims 1
- 206010029446 nocturia Diseases 0.000 claims 1
- 230000003169 placental effect Effects 0.000 claims 1
- 208000005333 pulmonary edema Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 208000013220 shortness of breath Diseases 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361785252P | 2013-03-14 | 2013-03-14 | |
| US61/785,252 | 2013-03-14 | ||
| PCT/US2014/025266 WO2014159826A1 (en) | 2013-03-14 | 2014-03-13 | Use of placental stem cells in treatment of acute kidney injury |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018206365A Division JP2019055955A (ja) | 2013-03-14 | 2018-11-01 | 急性腎損傷の治療における胎盤幹細胞の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016512555A JP2016512555A (ja) | 2016-04-28 |
| JP2016512555A5 true JP2016512555A5 (enExample) | 2017-04-13 |
Family
ID=51625261
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016501805A Pending JP2016512555A (ja) | 2013-03-14 | 2014-03-13 | 急性腎損傷の治療における胎盤幹細胞の使用 |
| JP2018206365A Pending JP2019055955A (ja) | 2013-03-14 | 2018-11-01 | 急性腎損傷の治療における胎盤幹細胞の使用 |
| JP2020180987A Withdrawn JP2021038229A (ja) | 2013-03-14 | 2020-10-29 | 急性腎損傷の治療における胎盤幹細胞の使用 |
| JP2022176132A Pending JP2023022018A (ja) | 2013-03-14 | 2022-11-02 | 急性腎損傷の治療における胎盤幹細胞の使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018206365A Pending JP2019055955A (ja) | 2013-03-14 | 2018-11-01 | 急性腎損傷の治療における胎盤幹細胞の使用 |
| JP2020180987A Withdrawn JP2021038229A (ja) | 2013-03-14 | 2020-10-29 | 急性腎損傷の治療における胎盤幹細胞の使用 |
| JP2022176132A Pending JP2023022018A (ja) | 2013-03-14 | 2022-11-02 | 急性腎損傷の治療における胎盤幹細胞の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20160030488A1 (enExample) |
| EP (1) | EP2968420B1 (enExample) |
| JP (4) | JP2016512555A (enExample) |
| DK (1) | DK2968420T3 (enExample) |
| ES (1) | ES2703784T3 (enExample) |
| PL (1) | PL2968420T3 (enExample) |
| PT (1) | PT2968420T (enExample) |
| WO (1) | WO2014159826A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3046078A1 (en) * | 2016-12-05 | 2018-06-14 | Celularity Inc. | Treatment of lymphedema and related conditions using placental adherent cells |
| US10932711B2 (en) | 2017-02-27 | 2021-03-02 | Payman Sadeghi | Method and system for neurohydrodissection |
| US10456419B2 (en) | 2017-02-27 | 2019-10-29 | Payman Sadeghi | Method for treating migraine headaches |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| KR101176146B1 (ko) * | 2002-02-13 | 2012-08-22 | 안트로제네시스 코포레이션 | 산후 포유류 태반으로부터 유래한 배아-유사 줄기 세포와그 세포를 사용한 용도 및 치료방법 |
| US7910755B2 (en) * | 2004-09-29 | 2011-03-22 | Harbor Biosciences, Inc. | Stem cell expansion and uses |
| PT2471904T (pt) * | 2005-12-29 | 2019-02-25 | Celularity Inc | População de células estaminais placentárias |
| EP3763376A1 (en) * | 2007-02-12 | 2021-01-13 | Celularity, Inc. | Treatment of inflammatory diseases using placental stem cells |
| US20090306625A1 (en) * | 2007-03-09 | 2009-12-10 | Angiodynamics, Inc. | Treatment systems and methods for renal-related diseases |
| JP5323845B2 (ja) * | 2007-10-05 | 2013-10-23 | エシコン・インコーポレイテッド | ヒト臍帯組織由来細胞を用いた腎組織の修復および再建 |
| LT2556145T (lt) * | 2010-04-07 | 2016-11-10 | Anthrogenesis Corporation | Angiogenezė naudojant placentos kamienines ląsteles |
| MX2012011543A (es) * | 2010-04-08 | 2013-05-06 | Anthrogenesis Corp | Tratamiento de sarcoidosis empleando celulas madre placentarias. |
| MX2014000567A (es) * | 2011-07-15 | 2014-05-01 | Anthrogenesis Corp | Tratamiento de lesion por radiacion utilizando celulas adherentes derivadas del amnios. |
-
2014
- 2014-03-13 JP JP2016501805A patent/JP2016512555A/ja active Pending
- 2014-03-13 PL PL14775592T patent/PL2968420T3/pl unknown
- 2014-03-13 DK DK14775592.0T patent/DK2968420T3/da active
- 2014-03-13 EP EP14775592.0A patent/EP2968420B1/en active Active
- 2014-03-13 ES ES14775592T patent/ES2703784T3/es active Active
- 2014-03-13 PT PT14775592T patent/PT2968420T/pt unknown
- 2014-03-13 US US14/774,262 patent/US20160030488A1/en not_active Abandoned
- 2014-03-13 WO PCT/US2014/025266 patent/WO2014159826A1/en not_active Ceased
-
2018
- 2018-11-01 JP JP2018206365A patent/JP2019055955A/ja active Pending
-
2019
- 2019-08-14 US US16/541,091 patent/US11696930B2/en active Active
-
2020
- 2020-10-29 JP JP2020180987A patent/JP2021038229A/ja not_active Withdrawn
-
2022
- 2022-11-02 JP JP2022176132A patent/JP2023022018A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523152A5 (enExample) | ||
| AR116031A2 (es) | Tratamiento de la sarcoidosis utilizando células madre placentarias | |
| HUE067965T2 (hu) | Pimobendán alkalmazása a szív méretének csökkentésére és a klinikai tünetek megjelenésének késleltetésére mitrális billentyûbetegség okozta tünetmentes szívelégtelenségben szenvedõ betegeknél | |
| JP2016512555A5 (enExample) | ||
| JP2016512817A5 (enExample) | ||
| JP2021529829A5 (enExample) | ||
| JP2014507482A5 (enExample) | ||
| HRP20240798T1 (hr) | Terapija matičnim stanicama kod patologija endometrija | |
| JP2015535291A5 (enExample) | ||
| HK1245117A1 (zh) | 使用调节释放索拉贝隆用於下尿路症状的组合物和方法 | |
| DOP2016000003A (es) | Formas de dosificación farmacéuticas estabilizadas que comprenden atrasentán | |
| WO2017070689A3 (en) | Solabegron zwitterion and uses thereof | |
| EA201491532A1 (ru) | Фармацевтические композиции для использования в комплексной терапии | |
| IL285187A (en) | Methods for treating symptoms and disorders associated with lysosomal storage diseases | |
| HK1232145A1 (zh) | 雙功能化合物和用於降低尿酸水平的用途 | |
| JP2014513121A5 (enExample) | ||
| WO2014130313A3 (en) | Methods and compositions relating to the treatment of cancer | |
| JP2014532758A5 (enExample) | ||
| JP2015516452A5 (enExample) | ||
| JP2013520509A5 (enExample) | ||
| JP2015516451A5 (enExample) | ||
| WO2013121300A3 (en) | Methods for treating psoriasis and vascular inflammation | |
| Gebhard et al. | Metastatic neuroendocrine tumors to the liver: treatment with bland embolization versus radioembolization | |
| JP2015516449A5 (enExample) | ||
| WO2015057403A3 (en) | Compositions and methods for treatment of inflammatory bowel disease |